Prevalence and Predictive Factors for Being High-risk of Obstructive Sleep Apnea Using Berlin Questionnaire in Polycystic Ovary Syndrome: Age - and BMI-Matched Study
Article Sidebar
Main Article Content
Abstract
Objectives: To evaluate prevalence and predictive factors for being high-risk of obstructive sleep apnea (OSA) in women with and without polycystic ovary syndrome (PCOS).
Materials and Methods: This age and body mass index matched cross-sectional study recruited 94 women with ages between 20 and 40 years. Risk of OSA was assessed by Berlin questionnaire in 47 women with PCOS diagnosed by the Rotterdam criteria and 47 women without PCOS.
Results: Women with PCOS had significantly greater waist circumference, waist-hip ratio, hyperandrogenism (HA), biochemical and clinical HA, and poorer metabolic parameters, that is, total cholesterol, low-density lipoprotein cholesterol and insulin, compared to women without PCOS. Women with PCOS revealed a statistically significantly higher prevalence in being high-risk of OSA than women without PCOS (27.7% vs 6.4%, p = 0.006). Impaired fasting glucose (IFG, fasting plasma glucose ≥ 100 mg/dL) was an independent predictor of high-risk for OSA using Berlin questionnaire with an odds ratio (95% confidence interval) of 29.19 (1.26-674.04).
Conclusion: The prevalence of being high-risk of OSA assessed by Berlin questionnaire was higher in women with PCOS than those without PCOS. IFG but not PCOS was a significant key predictive factor associated with the development of being high-risk of OSA. Consequently, we suggested OSA risk screening using Berlin questionnaire should be assessed in women with PCOS. Polysomnography should be offered to the patients who either are being high-risk of OSA identified by questionnaire screening tool or having insulin resistance.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745-9.
Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod 2012;27:3067-73.
Kumarendran B, O’Reilly MW, Manolopoulos KN, Toulis KA, Gokhale KM, Sitch AJ, et al. Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database. PLoS Med 2018;15:e1002542.
Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod 2018;33:1602-18.
Lee W, Nagubadi S, Kryger MH, Mokhlesi B. Epidemiology of Obstructive Sleep Apnea: a Population-based Perspective. Expert Rev Respir Med 2008;2:349-64.
Kapur VK, Auckley DH, Chowdhuri S, Kuhlmann DC, Mehra R, Ramar K, et al. Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med 2017;13:479-504.
Butt AM, Syed U, Arshad A. Predictive Value of Clinical and Questionnaire Based Screening Tools of Obstructive Sleep Apnea in Patients With Type 2 Diabetes Mellitus. Cureus 2021;13:e18009.
Romero-Corral A, Caples SM, Lopez-Jimenez F, Somers VK. Interactions between obesity and obstructive sleep apnea: implications for treatment. Chest 2010;137:711-9.
Teede HJ, Joham AE, Paul E, Moran LJ, Loxton D, Jolley D, et al. Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women. Obesity (Silver Spring) 2013;21:1526-32.
Kumarendran B, Sumilo D, O’Reilly MW, Toulis KA, Gokhale KM, Wijeyaratne CN, et al. Increased risk of obstructive sleep apnoea in women with polycystic ovary syndrome: a population-based cohort study. Eur J Endocrinol 2019;180:265-72.
Kahal H, Kyrou I, Uthman OA, Brown A, Johnson S, Wall PDH, et al. The prevalence of obstructive sleep apnoea in women with polycystic ovary syndrome: a systematic review and meta-analysis. Sleep Breath 2020;24:339-50.
Kahal H, Kyrou I, Tahrani AA, Randeva HS. Obstructive sleep apnoea and polycystic ovary syndrome: A comprehensive review of clinical interactions and underlying pathophysiology. Clin Endocrinol (Oxf) 2017;87:313-9.
Ehrmann DA. Metabolic dysfunction in pcos: Relationship to obstructive sleep apnea. Steroids 2012;77:290-4.
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-7.
Nishida C, Ko GT, Kumanyika S. Body fat distribution and noncommunicable diseases in populations: overview of the 2008 WHO Expert Consultation on Waist Circumference and Waist-Hip Ratio. Eur J Clin Nutr 2010;64:2-5.
Suksakorn S, Rattanaumpawan P, Banhiran W, Cherakul N, Chotinaiwattarakul W. Reliability and validity of a Thai version of the Berlin questionnaire in patients with sleep disordered breathing. J Med Assoc Thai 2014;97 Suppl 3:S46-56.
Banhiran W, Assanasen P, Nopmaneejumruslers C, Metheetrairut C. Epworth sleepiness scale in obstructive sleep disordered breathing: the reliability and validity of the Thai version. Sleep Breath 2011;15:571-7.
Sitasuwan T, Bussaratid S, Ruttanaumpawan P, Chotinaiwattarakul W. Reliability and validity of the Thai version of the Pittsburgh Sleep Quality Index. J Med Assoc Thai 2014;97 Suppl 3:S57-67.
Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 1999;131:485-91.
Grundy SM, Cleeman JI, Merz CN, Brewer HB, Jr., Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227-39.
Berek JS. Berek & Norvak’s Gynecology. 16 ed. Philadelphia, USA: Lippincott Williams & Wilkins 2012: 2102.
Classification and diagnosis of diabetes: standards of medical care in diabetes-2021. Diabetes Care 2021;44:S15-s33.
Wang Q, Guo T, Tao Y, Wang Q, Song Y, Huang W. Association between serum adipocyte factor level and insulin resistance in polycystic ovarian syndrome. Gynecol Endocrinol 2011;27:931-4.
Mokhlesi B, Scoccia B, Mazzone T, Sam S. Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women. Fertil Steril 2012;97:786-91.
Hachul H, Polesel DN, Tock L, Carneiro G, Pereira AZ, Zanella MT, et al. Sleep disorders in polycystic ovary syndrome: influence of obesity and hyperandrogenism. Rev Assoc Med Bras (1992) 2019;65:375-83.
Çaltekin MD, Hamamci M, Onat T, Kırmızı DA, Başer E, Yalvaç ES. Evaluation of sleep quality, restless legs syndrome, anxiety and depression in polycystic ovary syndrome. J Turkish Sleep Med 2021;3:243-9.
Almendros I, García-Río F. Sleep apnoea, insulin resistance and diabetes: the first step is in the fat. Eur Respir J 2017;49.
Seicean S, Kirchner HL, Gottlieb DJ, Punjabi NM, Resnick H, Sanders M, et al. Sleep-disordered breathing and impaired glucose metabolism in normal-weight and overweight/obese individuals: the Sleep Heart Health Study. Diabetes Care 2008;31:1001-6.
Kim NH, Cho NH, Yun CH, Lee SK, Yoon DW, Cho HJ, et al. Association of obstructive sleep apnea and glucose metabolism in subjects with or without obesity. Diabetes Care 2013;36:3909-15.